Skip to main content

Table 3 Distribution of antihypertensive drug combinations among hypertensive patients at Zewditu Memorial Hospital

From: Assessment of hypertension control and factors associated with the control among hypertensive patients attending at Zewditu Memorial Hospital: a cross sectional study

Combination of drugs

N = 225

%

Two drugs combination

100

44.4

 ACEI + BB

32

14.2

  Enala + ateno

32

14.2

 CCB + ACEI

28

12.4

  Nife + enala

25

11.1

  Enala + amlo

2

0.9

  Amlo + lisino

1

0.4

 CCB + BB

25

11.1

  Nife + ateno

21

9.3

  Ateno + amilo

2

0.9

  Nife + prop

2

0.9

 CCB + diuretic

6

2.7

  Nife + HCT

5

2.2

  Nife + furo

1

0.4

 ACEI + diuretic

5

2.2

  Enala + HCT

5

2.2

 BB + diuretic

4

1.8

  Ateno + HCT

3

1.3

  Furo + meto

1

0.4

Three drugs combination

79

35.1

 CCB + ACEI + BB

53

23.6

  Nife + enala + ateno

53

23.6

 ACEI + BB + diuretic

10

4.4

  Enala + ateno + HCT

8

3.6

  Enala + ateno + furo

2

0.9

 CCB + BB + diuretic

8

3.6

  Nife + ateno + HCT

6

2.7

  Nife + ateno + furo

2

0.9

 CCB + ACEI + diuretic

6

2.7

  Nife + enala + HCT

6

2.7

 BB + diuretic + diuretic

1

0.4

  Ateno + HCT + furo

1

0.4

 CCB + BB + ARB

1

0.4

  Nife + ateno + losa

1

0.4

Four drugs combination

8

3.6

 CCB + ACEI + BB + diuretic

6

2.7

  Nife + enala + ateno + HCT

5

2.2

  Nife + enala + ateno + furo

1

0.4

 ACEI + BB + diuretic + diuretic

1

0.4

  Enala + ateno + HCT + furo

1

0.4

 CCB + BB + diuretic + diuretic

1

0.4

  Nife + ateno + furo + spir

1

0.4

  1. ACEI angiotensin converting enzyme inhibitor, ARB angiotensin II receptor blocker, BB beta blocker, CCB calcium channel blocker, HCT hydrochlorothiazide, Amlo amlodipine, Ateno atenolol, Enala Enalapril, Furo Furosemide, Lisino Lisinopril, Losa losartan, Nife nifedipine, Prop propranolol, Meto Metoprolol, Spir spirinolactone